GNMT: a multifaceted suppressor of hepatocarcinogenesis

Abstract

Glycine N-methyltransferase (GNMT) exerts a pivotal role in the methionine cycle and, consequently, contributes to the control of methylation reactions, and purine and pyrimidine synthesis. Numerous observations indicate that GNMT is a tumor suppressor gene, but the molecular mechanisms of its suppressive action have only been partially unraveled to date. Present knowledge indicates that GNMT acts through both epigenetic and genetic mechanisms. Among them are the decrease of AKT signaling through the inhibition of the RAPTOR/mTOR complex and the interaction of GNMT with the PTEN inhibitor, PREX2. Furthermore, GNMT is a polycyclic aromatic hydrocarbon-binding protein and a mediator of the induction, by polycyclic hydrocarbons of the cytochrome P450-1A1 gene, whose polymorphism is involved in favoring different types of cancers. Finally, GNMT suppresses the expression of the transcription factor NRF2, whose overexpression is associated with HCC development. These findings suggest a multifaceted suppressor mechanism of the GNMT gene.

Keywords

GNMT / hepatocarcinogenesis / methionine cycle

References

[1] Liao YJ,Lee CM.Characterization of a glycine N-methyltransferase gene knockout mouse model for hepatocellular carcinoma: Implications of the gender disparity in liver cancer susceptibility.Int J Cancer 2009;124:816-26

[2] Martínez-Chantar ML,Ariz U.Loss of the glycine N-ethyltransferase gene leads to steatosis and hepatocellular carcinoma in mice.Hepatology2008;47:1191-9 PMCID:PMC2405897

[3] Liu SP,Lee CM.Higher susceptibility to aflatoxin B1-related hepatocellular carcinoma in glycine N-methyltransferase knockout mice.Int J Cancer2011;128;511-23

[4] JD. Methionine metabolism in mammals.J Nutr Biochem1990;1:228-37

[5] Pascale RM,Simile MM.Alterations of Methionine Metabolism as Potential Targets for the Prevention and Therapy of Hepatocellular Carcinoma.Medicina (Kaunas)2019;55:296 PMCID:PMC6631235

[6] Bremer J.Biosynthesis of choline in vitro.Biochim Biophys Acta 1960;37:173-5

[7] Blom HJ.Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects.J Inherit Metab Dis2011;34:75-81 PMCID:PMC3026708

[8] Cook RJ.Glycine N-methyltransferase is a folate binding protein of rat liver cytosol.Proc Natl Acad Sci U S A1984;81:3631-4 PMCID:PMC345272

[9] Wang YC,Lin YJ,Ko HA.Regulation of Folate-Mediated One-Carbon metabolism by GlycineN-Methyltransferase (GNMT) and Methylenetetrahydrofolate reductase (MTHFR).J Nutr Sci Vitaminol (Tokyo)2015;61:S148-50

[10] Williams KT.New insights into the regulation of methyl group and homocysteine metabolism.J Nutr2007;137:311‑4

[11] Reed MC,Hall MN.Mathematical analysis of the regulation of competing methyltransferases.BMC Syst Biol 2015;9:69 PMCID:PMC4606511

[12] Finkelstein JD.Inactivation of betaine-homocysteine methyltransferase by adenosylmethionine and adenosylethionine.Biochem Biophys Res Commun1984;118:14-9

[13] Ou X,Ramani K.Inhibition of human betaine-homocysteine methyltransferase expression by S-adenosylmethionine and methylthioadenosine.Biochem J2007;401:87-96 PMCID:PMC1698693

[14] Kutzbach C.Feedback inhibition in methylenetetrahydrofolate reductase in rat liver by S-adenosylmethionine.Biochim Biophys Acta1967;139:217-20

[15] Jencks DA.Allosteric inhibition of methylenetetrahydrofolate reductase by adenosylmethionine. Effects of adenosylmethionine and NADPH on the equilibrium between active and inactive forms of the enzyme and on the kinetics of approach to equilibrium.J Biol Chem 1987;262:2485‑93

[16] Wagner C,Cook RJ.Inhibition of glycine N-methyltransferase activity by folate derivatives: implications for regulation of methyl group metabolism.Biochem Biophys Res Commun1985;127:746-52

[17] Feo F,Garcea R.Effect of the variations of S-adenosyl-L-methionine liver content on fat accumulation and ethanol metabolism in ethanol-intoxicated rats.Toxicol Appl Pharmacol1986;83:331-41

[18] Lieber CS,DeCarli LM.S-adenosyl-L-ethionine attenuates alcohol-induced liver injury in the baboon.Hepatology1990;11:165-72

[19] Stramentinoli G,Galli-Kienle M.Protective role of S-adenosyl-methionine against acetaminophen induced mortality and hepatotoxicity in mice.Biochem Pharmacol 1979;28:3567-3571

[20] Corrales F,Alvarez L.S-adenosylmethionine treatment prevents carbon tetrachloride-induced S-adenosylmethionine synthetase inactivation and attenuates liver injury.Hepatology1992;16:1022-7

[21] Simile MM,Angioni E.5-Methylthioadenosine administration prevents lipid peroxidation and fibrogenesis induced in rat liver by carbon-tetrachloride intoxication.J Hepatol 2001;34:386-94

[22] Stramentinoli G,Ideo G.Protective role of S-adenosylmethionine on liver injury induced by D-galactosamine in rats.Biochem Pharmacol1978;27:1431-3

[23] Mato JM,Lu SC.S-adenosylmethionine: a control switch that regulates liver function.FASEB J2002;16:15-26

[24] Lu SC.Role of methionine adenosyltransferase and S-adenosylmethionine in alcohol-associated liver cancer.Alcohol2005;35:227-34

[25] Lu SC,Huang ZZ.Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation.Proc Natl Acad Sci U S A 2001;98:5560-5 PMCID:PMC33252

[26] Pascale RM,Satta G.Comparative effects of L-methionine, S-adenosyl-L-methionine and 5-methylthioadenosine on the growth of preneoplastic lesions and DNA methylation in rat liver during the early stages of hepatocarcinogenesis.Anticancer Res1991;11:1617-24

[27] Garcea R,Pascale RM.Inhibition of promotion and persistent nodule growth by S-adenosyl-L-methionine in rat liver carcinogenesis: role of remodeling and apoptosis.Cancer Res1989;49:1850-6

[28] Pascale RM,De Miglio MR.Chemoprevention by S-adenosyl-L-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promoted by orotic acid.Carcinogenesis1995;16:427-30

[29] Lu SC,Ou X.S-adenosylmethionine in the chemoprevention and treatment of hepatocellular carcinoma in a rat model.Hepatology 2009;50:462-471 PMCID:PMC2754739

[30] Torres L,Carretero MV.Liver-specific methionine adenosyltransferase MAT1A gene expression is associated with a specific pattern of promoter methylation and histone acetylation:implications for MAT1A silencing during transformation.FASEB J2000;14:95-102

[31] Tomasi ML,Li M,Lu SC.Inhibition of human methionine adenosyltransferase 1A transcription by coding region methylation.J Cell Physiol2012;227:1583-91 PMCID:PMC3183271

[32] Yang H,Zeng Z,Selby RR.Role of promoter methylation in increased methionine adenosyltransferase 2A expression in human liver cancer.Am J Physiol Gastrointest Liver Physiol2001;280:G184-90

[33] Frau M,Simile MM.Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression.Hepatology2012;56:165-75

[34] Feo F,Simile MM.Hepatocellular carcinoma as a complex polygenic disease. Interpretive analysis of recent developments on genetic predisposition.Biochim Biophys Acta2006;1765:126-47

[35] Lal A,Kawai T,Martindale JL.Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs.EMBO J2004;23:3092-102 PMCID:PMC514922

[36] Kim MY,Jeong S.Emerging roles of RNA and RNA-binding protein network in cancer cells.BMB Rep2009;42:125-130

[37] Vázquez-Chantada M,Embade N.HuR/-methyl-HuR and AUF1 regulate the MAT expressed during liver proliferation, differentiation, and carcinogenesis.Gastroenterology2010;138:1943-53 PMCID:PMC2860011

[38] Simile MM,Tomasi ML.MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting MAT2A and MAT2B genes.Oncotarget 2019;10:2835-54 PMCID:PMC6497462

[39] Yang H,Li TW.MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma.J Clin Invest2013;123:285-98 PMCID:PMC3533284

[40] Yeo EJ.Tissue distribution of glycine N-methyltransferase, a major folate-binding protein of liver.Proc Natl Acad Sci U S A1994;91:210-4 PMCID:PMC42916

[41] Avila MA,Torres L.Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma.J Hepatol 2000;33:907-14

[42] Frau M,Pascale RM.Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.J Hepatol2013;59:830-41

[43] Chen YM,Tzeng SJ.Characterization of glycine-N-methyltransferase-gene expression in human hepatocellular carcinoma.Int J Cancer 1998;75:787-93

[44] Kant R,Lu CK,Li JH.Identification of 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranoside as a Glycine-n-methyltransferase enhancer by high-throughput screening of natural products inhibits hepatocellular carcinoma.Int J Mol Sci 2016;17:669 PMCID:PMC4881495

[45] Heady JE.Alteration of glycine N-methyltransferase activity: fetal, adult, and tumor tissues.Cancer Res1975;35:640-3

[46] Botezatu A,Nastase A.Epigenetic silencing of GNMT gene in pancreatic adenocarcinoma.Cancer Genomics Proteomics2015;12:21-30

[47] Huidobro C,Fernández AF.A DNA methylation signature associated with the epigenetic repression of glycine N-methyltransferase in human hepatocellular carcinoma.J Mol Med (Berl)2013;91:939-50

[48] Bhat R.Glycine N-methyltransferase is an example of functional diversity. Role as a polycyclic aromatic hydrocarbon binding receptor.J Biol Chem 1997;272:21221-6

[49] Chen SY,Darbha R,Liu TY.Glycine N-methyltransferase tumor susceptibility gene in the benzo(a)pyrene detoxification pathway.Cancer Res 2004;64:3617-23

[50] Yen CH,Ueng YF.Glycine N-methyltransferase affects the metabolism of aflatoxin B1 and blocks its carcinogenic effect.Toxicol Appl Pharmacol 2009;235:296-304

[51] Tseng TL,Huang YC.Genotypic and phenotypic characterization of a putative tumor susceptibility gene, GNMT, in liver cancer.Cancer Res 2003;63:647-54

[52] Huang YC,Chen M.Haplotypes, loss of heterozygosity, and expression levels of glycine N-methyltransferase in prostate cancer.Clin Cancer Res 2007;13:1412-20

[53] Chen M,Huang YC.Genetic polymorphisms of the glycine N-methyltransferase and prostate cancer risk in the health professionals follow-up study.PLoS One2014;9:e94683 PMCID:PMC4011739

[54] Ottaviani S,O’Hanlon-Brown C,Ali S.Characterisation of the androgen regulation of glycine N-methyltransferase in prostate cancer cells.J Mol Endocrinol 2013;51:301-12 PMCID:PMC3821059

[55] Lee CM,Tzeng TY.Androgen response element of the glycine N-ethyltransferase gene is located in the coding region of its first exon.Biosci Rep2013;3 3(5):e00070 PMCID:PMC3775523

[56] Luka Z., Mato JM, Wagner C. A glycine N-methyltransferase knockout mouse model for humans with deficiency of this enzyme.Transgenic Res2006;15:393-7 PMCID:PMC2792375

[57] Martínez-López N,Varela-Rey M.Hepatoma cells from mice deficient in glycine N-methyltransferase have increased RAS signaling and activation of liver kinase B1.Gastroenterology2012;143:787-98 PMCID:PMC3429651

[58] Yang C,Liu Z,Wang C.Metabolism-associated molecular classification of hepatocellular carcinoma.Mol Oncol2020;14:896-913 PMCID:PMC7138397

[59] Frau M,Tomasi ML.An expression signature of phenotypic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis.Cell Oncol (Dordr)2012;35:163-73 PMCID:PMC4517440

[60] Yi L,Yin J,Li G.Proteomics analysis of liver tissues from C57BL/6J mice receiving low-dose 137Cs radiation.Environ Sci Pollut Res Int 2016;23:2549-56

[61] Farber E.Cloncal adaption during carcinogenesis.Biochem Pharmacol 1990;39:1837-46

[62] Martinez-Chantar ML,Mato JM.The role of stem cells/progenitor cells in liver carcinogenesis in glycine N-methyltransferase deficient mice.Exp Mol Pathol 2010;88:234-7 PMCID:PMC3030975

[63] Li J,Dedes J.S-adenosylmethionine prevents Mallory Denk body formation in drug-primed mice by inhibiting the epigenetic memory.Hepatology 2008;47:613-24 PMCID:PMC2874456

[64] Hoeffer CA.mTOR signaling: at the crossroads of plasticity, memory and disease.Trends Neurosci 2010;33:67-75 PMCID:PMC2821969

[65] Yen CH,Li CH.Functional characterization of glycine N-methyltransferase and its interactive protein DEPDC6/DEPTOR in hepatocellular carcinoma.Mol Med 2012;18:286-96 PMCID:PMC3324955

[66] Li CH,Chen YF.Characterization of the GNMT HectH9-PREX2 tripartite relationship in the pathogenesis of hepatocellular carcinoma.Int J Cancer 2017;140:2284-97

[67] He S,Yu S.Upregulation of PREX2 promotes the proliferation and migration of hepatocellular carcinoma cells via PTEN-AKT signaling. Oncol Lett 2016;11:2223-8. PMCID:PMC4774577

[68] DebRoy S,Ghose S,Krupenko SA.A novel tumor suppressor function of glycine N-methyltransferase is independent of its catalytic activity but requires nuclear localization.PLoS One2013;8:e70062 PMCID:PMC3728347

[69] Krupenko NI.Transport of rat liver glycine N-methyltransferase into rat liver nuclei.J Biol Chem1997;272:27140-6

[70] Wang YC,Lin YJ,Chen YM.A novel role of the tumor suppressor GNMT in cellular defense against DNA damage.Int J Cancer 2014;134:799-810

[71] Raha A,Gusky S.Glycine N-methyltransferase is a mediator of cytochrome P4501A1 gene expression.Arch Biochem Biophys 1995;322:395-404

[72] Masson LF,Cotton SC.Cytochrome P-450 1A1 gene polymorphisms and risk of breast cancer: a HuGE review.Am J Epidemiol2005;161:901-15

[73] Ding B,Han S,Ren M.Cytochrome P450 1A1 gene polymorphisms and cervical cancer risk: A systematic review and meta-analysis.Medicine (Baltimore)2018;97:e0210 PMCID:PMC5895380

[74] Wei XP.Cytochrome P450 1A1 exon 7 polymorphism and susceptibility to lung cancer in the Chinese population: an updated meta-analysis and review.Onco-Targets Ther2015;8:1611-8 PMCID:PMC4494617

[75] Yu MW,Yang SY.Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers.Br J Cancer 1999;80:598-603 PMCID:PMC2362308

[76] de la Vega M, Chapman E, Zhang DD. NRF2 and the Hallmarks of Cancer.Cancer Cell 2018;34:21-43 PMCID:PMC6039250

[77] Carvajal-Yepes M,Schaedler S.Hepatitis C virus impairs the induction of cytoprotective Nrf2 target genes by delocalization of small Maf proteins.J Biol Chem2011;286:8941-51 PMCID:PMC3058995

[78] Yen CH.NRF2 is one of the players involved in bone marrow mediated drug resistance in multiple myeloma.Int J Mol Sci2018;19:3503 PMCID:PMC6274683

[79] Wu HC,Yen CH,Chen IS.Chemical constituents with GNMT-promoter-enhancing and NRF2-reduction activities from taiwan agarwood excoecaria formosana.Molecules 2020;25:1746 PMCID:PMC7181199

[80] Fernández-Ramos D,Lopitz-Otsoa F.MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis.Cell Death Dis 2018;9:958 PMCID:PMC6148053

[81] Fernández-Tussy P,Lopitz-Otsoa F.miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease.Mol Metab 2019;29:40-54 PMCID:PMC6728756

[82] Kant R,Hung JH.Induction of GNMT by 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranoside through proteasome-independent MYC downregulation in hepatocellular carcinoma.Sci Rep 2019;9:1968 PMCID:PMC6374375

[83] Watson WH,Kirpich IA,Chen T.Ethanol exposure modulates hepatic S-adenosylmethionine and S-adenosylhomocysteine levels in the isolated perfused rat liver through changes in the redox state of the NADH/NAD(+) system.Biochim Biophys Acta 2011;181:613-8 PMCID:PMC3771647

[84] Pascale RM,De Miglio MR.Chemoprevention of hepatocarcinogenesis: S-adenosyl-L-methionine.Alcohol 2002;27:193-8

[85] Sueblinvong V,Saghafi R,Fan X.Chronic alcohol ingestion primes the lung for bleomycin-induced fibrosis in mice.Alcohol Clin Exp Res 2014;38:336-43 PMCID:PMC3869877

[86] Pascale R,Garcea R.Inhibition by ethanol of rat liver plasma membrane (Na+,K+)ATPase: protective effect of S-adenosyl-L-methionine, L-methionine, and N-acetylcysteine.Toxicol Appl Pharmacol 1989;97:216-29